Involvement of chronic epipharyngitis in autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA).
The epipharynx is an immunologically active site even under normal conditions, and enhanced immunologic activation is prone to occur in response to an upper respiratory infection, air pollution, and possibly to vaccine adjuvants. Due to the potential link between the central nervous system and immune function, a relationship between epipharyngitis and autonomic nervous disturbance as well as autoimmune disease has been suggested. Various functional somatic symptoms have been described after human papillomavirus (HPV) vaccination, although a causal relationship has not been established. We examined the epipharynx in young women showing functional somatic symptoms following HPV vaccination. Surprisingly, despite having minimal symptoms involving the pharynx, all patients were found to have severe epipharyngitis. In addition, significant improvement in symptoms was seen in most patients who underwent epipharyngeal treatment. Thus, we speculate that the chronic epipharyngitis potentially caused by the vaccine adjuvant may be involved in the pathogenesis of functional somatic syndrome (FSS) post-HPV vaccination. Further, we suggest that epipharyngeal treatment may be effective for various types of FSS regardless of the initial cause, as well as for some autoimmune diseases, and that this may be an important direction in future research.
Division of Internal Medicine, Hotta Osamu Clinic, 2-39 Rokuchounome-minamimachi, Wakabayashi-ku, Sendai, Miyagi, 984-0013, Japan. hottao@remus.dti.ne.jp.
Osamu
O
Hotta
Tanaka ENT Clinic, Osaka, Japan.
Ayaki
A
Tanaka
Division of Internal Medicine, Hotta Osamu Clinic, 2-39 Rokuchounome-minamimachi, Wakabayashi-ku, Sendai, Miyagi, 984-0013, Japan.
Akira
A
Torigoe
Mirai Clinic, Fukuoka, Japan.
Kazuaki
K
Imai
Division of Internal Medicine, Hotta Osamu Clinic, 2-39 Rokuchounome-minamimachi, Wakabayashi-ku, Sendai, Miyagi, 984-0013, Japan.
Norio
N
Ieiri
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000277:Adjuvants, Pharmaceutic / Q000009:adverse effects*; D000293:Adolescent; D000328:Adult; D001327:Autoimmune Diseases / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D053918:Papillomavirus Vaccines / Q000009:adverse effects; D010608:Pharyngeal Diseases / Q000209:etiology* / Q000473:pathology; D010614:Pharynx / Q000473:pathology; D013577:Syndrome; D014611:Vaccination / Q000009:adverse effects; D055815:Young Adult
D000276:Adjuvants, Immunologic; D000277:Adjuvants, Pharmaceutic; D053918:Papillomavirus Vaccines
Adjuvant; Chronic epipharyngitis; Functional somatic syndrome; Human papillomavirus vaccine